Atossa Therapeutics
ATOS
ATOS
83 hedge funds and large institutions have $45.4M invested in Atossa Therapeutics in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 36 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
37% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 19
58% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 36
Holders
83
Holding in Top 10
–
Calls
$2.57M
Puts
$2.87M
Top Buyers
| 1 | +$1.16M | |
| 2 | +$764K | |
| 3 | +$453K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$114K |
| 5 |
Franklin Resources
San Mateo,
California
|
+$89K |
Top Sellers
| 1 | -$2.27M | |
| 2 | -$1.15M | |
| 3 | -$1M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$461K |
| 5 |
D.E. Shaw & Co
New York
|
-$356K |